RareCyte Investor

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Invests into

Technology: Metabolic Disorders
Industry: PharmTech
Headquarters: Seattle, Washington, United States
Founded Date: 2009-01-01
Employees Number: 11-50
Funding Status: Late Stage Venture
Estimated Revenue: $1M to $10M

Visit Website
info@rarecyte.com
https://twitter.com/RareCyte
Register and Claim Ownership